Noble Capital Markets initiated coverage on Tonix Pharma
$TNXP
Biotechnology: Pharmaceutical Preparations
Health Care
Noble Capital Markets initiated coverage of Tonix Pharma with a rating of Outperform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/18/2022 | Outperform | Noble Capital Markets |
4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)